{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:09:51Z","timestamp":1762099791352},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1054\/mehy.1999.1012","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T15:33:28Z","timestamp":1032449608000},"page":"195-198","source":"Crossref","is-referenced-by-count":6,"title":["Glucosamine for migraine prophylaxis?"],"prefix":"10.1054","volume":"55","author":[{"given":"A.L.","family":"Russell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.F.","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/mehy.1999.1012_RF1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0306-9877(94)90007-8","article-title":"The neglect of glucosamine as a treatment for osteoarthritis \u2013 a personal perspective","volume":"42","author":"McCarty","year":"1994","journal-title":"Med Hypotheses"},{"key":"10.1054\/mehy.1999.1012_RF2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0306-9877(97)90328-5","article-title":"Glucosamine may retard atherogenesis by promoting endothelial production of heparan sulfate proteoglycans","volume":"48","author":"McCarty","year":"1997","journal-title":"Med Hypotheses"},{"key":"10.1054\/mehy.1999.1012_RF3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0306-9877(98)90247-X","article-title":"Vascular heparan sulfates may limit the ability of leukocytes to penetrate the endothelial barrier \u2013 implications for use of glucosamine in inflammatory disorders","volume":"51","author":"McCarty","year":"1998","journal-title":"Med Hypotheses"},{"key":"10.1054\/mehy.1999.1012_RF4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1526-4610.1973.hed1302049.x","article-title":"Heparin in migraine headache","volume":"13","author":"Thonnard-Neumann","year":"1973","journal-title":"Headache"},{"key":"10.1054\/mehy.1999.1012_RF5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1526-4610.1976.hed1606284.x","article-title":"Migraine therapy with heparin: pathophysiologic basis","volume":"16","author":"Thonnard-Neumann","year":"1977","journal-title":"Headache"},{"key":"10.1054\/mehy.1999.1012_RF6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1526-4610.1988.hed2802114.x","article-title":"Prophylaxis of migraine with anionic polyelectrolytes","volume":"28","author":"Thonnard-Neumann","year":"1988","journal-title":"Headache"},{"key":"10.1054\/mehy.1999.1012_RF7","first-page":"325","article-title":"T-lymphocytes in migraine","volume":"47","author":"Thonnard-Neumann","year":"1981","journal-title":"Ann Allergy"},{"key":"10.1054\/mehy.1999.1012_RF8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1023\/A:1003274915675","article-title":"Ribonuclease-gold labels chondroitin sulphate in guinea pig basophil granules","volume":"30","author":"Dvorak","year":"1998","journal-title":"Histochem J"},{"key":"10.1054\/mehy.1999.1012_RF9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0306-3623(94)00170-R","article-title":"Heparin: pharmacological potentials from atherosclerosis to asthma","volume":"26","author":"Ragazzi","year":"1995","journal-title":"Gen Pharmacol"},{"key":"10.1054\/mehy.1999.1012_RF10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1054-3589(08)60471-8","article-title":"Heparin in inflammation: potential therapeutic applications beyond anticoagulation","volume":"46","author":"Tyrrell","year":"1999","journal-title":"Adv Pharmacol"},{"key":"10.1054\/mehy.1999.1012_RF11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1152\/jappl.1994.76.2.893","article-title":"Heparin prevents antigen-induced airway hyperresponsiveness: interference with IP3-mediated mast cell degranulation?","volume":"76","author":"Ahmed","year":"1994","journal-title":"J Appl Physiol"},{"key":"10.1054\/mehy.1999.1012_RF12","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1164\/ajrccm.153.5.8630624","article-title":"Time course of the protective effect of inhaled heparin on exercise-induced asthma","volume":"153","author":"Garrigo","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1054\/mehy.1999.1012_RF13","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1164\/ajrccm.155.6.9196085","article-title":"Inhibition of antigen-induced acute bronchoconstriction, airway hyperresponsiveness, and mast cell degranulation by a nonanticoagulant heparin: comparison with a low molecular weight heparin","volume":"155","author":"Ahmed","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1054\/mehy.1999.1012_RF14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1152\/jappl.1998.84.1.222","article-title":"Inhibition of allergic airway responses by inhaled low-molecular-weight heparins: molecular-weight dependence","volume":"84","author":"Martinez-Salas","year":"1998","journal-title":"J Appl Physiol"},{"key":"10.1054\/mehy.1999.1012_RF15","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1353\/pbm.1983.0028","article-title":"Mast cells and migraines","volume":"26","author":"Theoharides","year":"1983","journal-title":"Perspect Biol Med"},{"key":"10.1054\/mehy.1999.1012_RF16","first-page":"S16","article-title":"Neurogenic inflammation in the pathophysiology and treatment of migraine","volume":"43","author":"Moskowitz","year":"1993","journal-title":"Neurology"},{"key":"10.1054\/mehy.1999.1012_RF17","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1210\/endo.136.12.7588332","article-title":"Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect","volume":"136","author":"Theoharides","year":"1995","journal-title":"Endocrinology"},{"key":"10.1054\/mehy.1999.1012_RF18","first-page":"1","article-title":"The mast cell: a neuroimmunoendocrine master player","volume":"18","author":"Theoharides","year":"1996","journal-title":"Int J Tissue React"},{"key":"10.1054\/mehy.1999.1012_RF19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2222.1991.tb01757.x","article-title":"Biological properties of human skin mast cells","volume":"21","author":"Church","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1054\/mehy.1999.1012_RF20","doi-asserted-by":"crossref","first-page":"9651","DOI":"10.1016\/S0021-9258(17)36931-4","article-title":"Characterization of the substance P receptor-mediated calcium influx in cDNA transfected Chinese hamster ovary cells. A possible role of inositol 1,4,5-trisphosphate in calcium influx","volume":"269","author":"Mochizuki-Oda","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1054\/mehy.1999.1012_RF21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2222.1982.tb01633.x","article-title":"Increased plasma histamine levels in migraine patients","volume":"12","author":"Heatley","year":"1982","journal-title":"Clin Allergy"},{"key":"10.1054\/mehy.1999.1012_RF22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1468-2982.1984.0402097.x","article-title":"Histamine release from leucocytes during migraine attack","volume":"4","author":"Selmaj","year":"1984","journal-title":"Cephalalgia"},{"key":"10.1054\/mehy.1999.1012_RF23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1468-2982.1991.1104165.x","article-title":"Evidence for 5-HT1B\/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine","volume":"11","author":"Buzzi","year":"1991","journal-title":"Cephalalgia"},{"key":"10.1054\/mehy.1999.1012_RF24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0006-8993(10)80017-4","article-title":"5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation","volume":"583","author":"Buzzi","year":"1992","journal-title":"Brain Res"},{"key":"10.1054\/mehy.1999.1012_RF25","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.1990.03450130083031","article-title":"Low-dose aspirin for migraine prophylaxis [see comments]","volume":"264","author":"Buring","year":"1990","journal-title":"JAMA"},{"key":"10.1054\/mehy.1999.1012_RF26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0306-9877(96)90158-9","article-title":"Magnesium taurate and fish oil for prevention of migraine","volume":"47","author":"McCarty","year":"1996","journal-title":"Med Hypotheses"},{"key":"10.1054\/mehy.1999.1012_RF27","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/archneur.1981.00510050068012","article-title":"Cluster headache. Ultrastructural aspects and pathogenetic mechanisms","volume":"38","author":"Appenzeller","year":"1981","journal-title":"Arch Neurol"},{"key":"10.1054\/mehy.1999.1012_RF28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1468-2982.1984.0402101.x","article-title":"Mast cells in cluster headache. Ultrastructure, release pattern and possible pathogenetic significance","volume":"4","author":"Liberski","year":"1984","journal-title":"Cephalalgia"},{"key":"10.1054\/mehy.1999.1012_RF29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1468-2982.1990.1005221.x","article-title":"Cluster headache: ultrastructural evidence for mast cell degranulation and interaction with nerve fibres in the human temporal artery","volume":"10","author":"Dimitriadou","year":"1990","journal-title":"Cephalalgia"},{"key":"10.1054\/mehy.1999.1012_RF30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1749-6632.1998.tb09601.x","article-title":"Interstitial cystitis: a neuroimmunoendocrine disorder","volume":"840","author":"Theoharides","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1054\/mehy.1999.1012_RF31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0192-0561(98)00054-X","article-title":"C. Hydroxyzine inhibits neurogenic bladder mast cell activation","volume":"20","author":"Minogiannis","year":"1998","journal-title":"Int J Immunopharmacol"},{"key":"10.1054\/mehy.1999.1012_RF32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0090-4295(99)80469-5","article-title":"Mast cell and substance P-positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis","volume":"47","author":"Pang","year":"1996","journal-title":"Urology"},{"key":"10.1054\/mehy.1999.1012_RF33","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1440-1746.1998.tb00558.x","article-title":"Mast cells: a possible link between psychological stress, enteric infection, food allergy and gut hypersensitivity in the irritable bowel syndrome","volume":"13","author":"Gui","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1054\/mehy.1999.1012_RF34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2982.1997.d01-63.x","article-title":"Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells","volume":"9","author":"Gue","year":"1997","journal-title":"Neurogastroenterol Motil"},{"key":"10.1054\/mehy.1999.1012_RF35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0016-5085(90)91238-2","article-title":"Enhancement of human intestinal mast cell mediator release in active ulcerative colitis","volume":"99","author":"Fox","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1054\/mehy.1999.1012_RF36","first-page":"60","article-title":"[Histochemical properties of the heparin-protein complex of mast cells and the state of the blood coagulating system in a primary lesion focus of non-specific ulcerative colitis]","volume":"38","author":"Shubnich","year":"1976","journal-title":"Arkh Patol"},{"key":"10.1054\/mehy.1999.1012_RF37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00005072-199706000-00001","article-title":"Mast cell interactions with the nervous system: relationship to mechanisms of disease","volume":"56","author":"Dines","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1054\/mehy.1999.1012_RF38","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1365-2036.1997.00252.x","article-title":"Treatment of corticosteroid-resistant ulcerative colitis with heparin \u2013 a report of 16 cases","volume":"11","author":"Evans","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1054\/mehy.1999.1012_RF39","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/j.1572-0241.1999.01143.x","article-title":"Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease","volume":"94","author":"Folwaczny","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1054\/mehy.1999.1012_RF40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/00365598509180218","article-title":"Subcutaneous heparin in the treatment of interstitial cystitis","volume":"19","author":"Lose","year":"1985","journal-title":"Scand J Urol Nephrol"},{"key":"10.1054\/mehy.1999.1012_RF41","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1464-410X.1994.tb07634.x","article-title":"Treatment of interstitial cystitis with intravescical heparin [see comments]","volume":"73","author":"Parsons","year":"1994","journal-title":"Br J Urol"},{"key":"10.1054\/mehy.1999.1012_RF42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0306-9877(98)90060-3","article-title":"Glucosamine in osteoarthritis and gastrointestinal disorders: an exemplar of the need for a paradigm shift","volume":"51","author":"Russell","year":"1998","journal-title":"Med Hypotheses"},{"key":"10.1054\/mehy.1999.1012_RF43","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0039-6060(96)80256-X","article-title":"Increased mast cell infiltration in varicose veins of the lower limbs: a possible role in the development of varices","volume":"119","author":"Yamada","year":"1996","journal-title":"Surgery"},{"key":"10.1054\/mehy.1999.1012_RF44","first-page":"443","article-title":"Ultrastructural demonstration of mast cells in varicose veins of lower limbs: presence of mast cell-mediated mechanism","volume":"38","author":"Yamada","year":"1997","journal-title":"J Cardiovasc Surg"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987799910125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987799910125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T06:34:59Z","timestamp":1621146899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987799910125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S0306987799910125"],"URL":"https:\/\/doi.org\/10.1054\/mehy.1999.1012","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}